Inger Johanne Bakken

Inger Johanne Bakken

Auto-generated profile, based on publicly available information

Inger Johanne Bakken

Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2019 in Scandinavian Journal of Public Health
Verified
Journal Article
Closed access
PDF file
IBInger Johanne Bakken
Inger Johanne Bakken
AAAnja M. S. Ariansen
Anja M. S. Ariansen
GKGun Peggy Knudsen
Gun Peggy Knudsen
KJKnut Ivar Johansen
Knut Ivar Johansen
SVStein Emil Vollset
Stein Emil Vollset
In Norway, the Directorate of Health is responsible for two nationwide registries – the Norwegian Patient Registry (NPR) and the Norwegian Registry for Primary Health Care (NRPHC) – which together cover all governmental-funded health care. The NPR (specialist health care) was established in 2008, while the NRPHC (primary health care) was established in 2017. Data from the NPR are extensively used in a large variety of studies. We expect that data from the NRPHC will increase in importance when the registry covers a longer time period. The NRPHC will be especially important for studying conditions mainly treated in primary care and for investigation of patient trajectories. The main aim of this paper is to give an overview of the history and content of the NPR and its research possibilities. In addition, we introduce the NRPHC as a possible future research tool and the potential for studying patient trajectories when combining data from the two registries.

24 February 2009 in Scandinavian Journal of Psychology
Verified
Journal Article
Closed access
PDF file
IBInger Johanne Bakken
Inger Johanne Bakken
HWHanne Gro Wenzel
Hanne Gro Wenzel
KGK. Gunnar Götestam
K. Gunnar Götestam
AJAgneta Johansson
Agneta Johansson
AØAnita Øren
Anita Øren

1 July 2012 in Pediatrics
Verified
Journal Article
Open access
PDF file
PSPål Surén
Pål Surén
IBInger Johanne Bakken
Inger Johanne Bakken
HAHeidi Aase
Heidi Aase
RCRichard Chin
Richard Chin
NGNina Gunnes
Nina Gunnes
CSCamilla Stoltenberg
Camilla Stoltenberg
BACKGROUND: Numerous studies have investigated the prevalence of neurologic and neurodevelopmental disorders individually, but few have examined them collectively, and there is uncertainty as to what extent they overlap.METHODS: The study has determined the proportions of children aged 0 to 11 years with diagnoses of autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), epilepsy, and cerebral palsy (CP) in Norway. The data were obtained from the Norwegian Patient Register, which is nationwide and contains diagnoses assigned by Norwegian specialist health services (hospitals and outpatient clinics). The Norwegian Patient Register started collecting individual-level data in 2008, and the follow-up period for the study is years 2008 through 2010.RESULTS: For ASD, ADHD, and epilepsy, the proportions were highest in the oldest children. At age 11 years, the incidence was 0.7% for ASD, 2.9% for ADHD, and 0.9% for epilepsy. The cumulative incidence is likely to be higher because some cases diagnosed before 2008 were probably missed. For CP, the proportions were ∼0.3% for age ≥5 years. There was considerable overlap between diagnoses. For all disorders, boys had a significantly increased risk. In school-age children (aged 6–11 years) the male/female ratio was 4.3 for ASD, 2.9 for ADHD, 1.2 for epilepsy, and 1.3 for CP.CONCLUSIONS: The findings demonstrate the significant burden of disease associated with neurologic and neurodevelopmental disorders in children and that this burden is disproportionately skewed toward boys.

1 September 2016 in Pediatrics
Verified
Journal Article
Closed access
PDF file
KAKari Modalsli Aaberg
Kari Modalsli Aaberg
IBInger Johanne Bakken
Inger Johanne Bakken
MLMorten I. Lossius
Morten I. Lossius
CSCamilla Lund Søraas
Camilla Lund Søraas
SHSiri Eldevik Håberg
Siri Eldevik Håberg
RCRichard Chin
Richard Chin
BACKGROUND AND OBJECTIVE: Children with epilepsy are at increased risk of other disorders and difficulties, preceding, cooccurring with, or after the diagnosis of epilepsy. Risk estimates vary, few studies are population-based, and few provide comprehensive assessments of comorbidities. We used nationwide registry data to describe frequencies of medical, neurologic, developmental, and psychiatric conditions occurring before and after children are diagnosed with childhood epilepsy.METHODS: Data were obtained from the Norwegian Patient Registry, which is an administrative database recording International Classification of Diseases, 10th Revision diagnoses from all government-funded specialist health services in Norway (outpatient consultations and hospitalizations). We included data from the years 2008 through 2013 for all children born in Norway between 1996 and 2013 (0–17 years of age at the end of follow-up). Children with epilepsy were compared with the general child population, adjusting for sex and age. We also compared children with complicated epilepsies (ie, epilepsies with additional neurologic and/or developmental disorders) to children with uncomplicated epilepsies.RESULTS: The study population included 1 125 161 children. There were 6635 (0.6%) children with epilepsy. Nearly 80% of children with epilepsy had ≥1 comorbid disorder. All types of disorders were more frequent in children with epilepsy, with additional medical disorders recorded in 55%, neurologic disorders in 41%, and developmental/psychiatric disorders in 43%. Children with complicated epilepsies had the highest overall levels of comorbidity, but the risk of medical and psychiatric comorbidities was also substantial among children with uncomplicated epilepsies.CONCLUSIONS: The overall frequency of comorbid disease is high in children with epilepsy, including children with presumably uncomplicated epilepsies.

29 July 1999 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Open access
PDF file
KKKjell A. Kvistad
Kjell A. Kvistad
IBInger J. Bakken
Inger J. Bakken
IGIngrid S. Gribbestad
Ingrid S. Gribbestad
BRBenny Ehrnholm Rt
Benny Ehrnholm Rt
SLSteinar Lundgren
Steinar Lundgren
OHOlav Haraldseth
Olav Haraldseth
The purpose of this study was to evaluate whether the detection of choline‐containing compounds in in vivo 1H magnetic resonance spectroscopy (MRS) of breast lesions is specific for carcinomas, whether a choline peak in in vivo 1H MRS can be detected under physiological conditions of increased metabolism in breast parenchyma, and whether analysis of lipid signals can differentiate between various breast lesions and tissues. Forty patients and volunteers were examined with in vivo 1H MR spectroscopy. Three spectra with identical localization but increasing echo times were obtained. Choline‐containing compounds were detected in 9 of 11 carcinomas and in 2 of 11 benign lesions. A choline signal was also detected in five of seven volunteers who were breast‐feeding at the time of examination, demonstrating that choline compounds can be detected by in vivo 1H MRS in breast tissue under physiological conditions. Analysis of lipid signals did not contribute to differentiation between various breast lesions and tissues. J. Magn. Reson. Imaging 1999;10:159–164.

25 January 2011 in Scandinavian Journal of Psychology
Verified
Journal Article
Closed access
PDF file
RDRuth Derdikman‐Eiron
Ruth Derdikman‐Eiron
MIMarit S. Indredavik
Marit S. Indredavik
GBGrete H. Bratberg
Grete H. Bratberg
GTGunnar Taraldsen
Gunnar Taraldsen
IBInger Johanne Bakken
Inger Johanne Bakken
MCMatthew Colton
Matthew Colton